نتایج جستجو برای: hbv escape mutations

تعداد نتایج: 214596  

Journal: :Expert opinion on biological therapy 2008
Sinan Akay Zeki Karasu

Post-transplant hepatitis B virus (HBV) recurrence prophylaxis is a sine qua non of liver transplantation for HBV-related liver disease because of high rate and aggressive course of HBV recurrence. Hepatitis B immune globulin (HBIG) is a polyclonal immune globulin solution obtained from plasma, donated by individuals with high titres of anti-HBs (hepatitis B antibody). Although it was being use...

Journal: :hepatitis monthly 0
rym ayari laboratory of immunology research center, kidney transplantation and immunopathology (lr03sp01), charles nicolle hospital, university of tunis el manar, tunisia +216-25462623, [email protected]; laboratory of immunology research center, kidney transplantation and immunopathology (lr03sp01), charles nicolle hospital, university of tunis el manar, tunisia +216-25462623, [email protected] yousr lakhoua-gorgi laboratory of immunology research center, kidney transplantation and immunopathology (lr03sp01), charles nicolle hospital, university of tunis el manar, tunisia +216-25462623, [email protected] lamjed bouslama borj cedria center for biotechnology, hammam lif, tunisia imen safar laboratory of immunology research center, kidney transplantation and immunopathology (lr03sp01), charles nicolle hospital, university of tunis el manar, tunisia +216-25462623, [email protected] fatma houissa kchouk laboratory of immunology research center, kidney transplantation and immunopathology (lr03sp01), charles nicolle hospital, university of tunis el manar, tunisia +216-25462623, [email protected] houda aouadi laboratory of immunology research center, kidney transplantation and immunopathology (lr03sp01), charles nicolle hospital, university of tunis el manar, tunisia +216-25462623, [email protected]

background in this study, we evaluated the prevalence of the most common mutations occurring in enhancer ii (enhii), basal core promoter (bcp), precore (pc), and core (c) regions of hepatitis b virus (hbv) genome. objectives we also investigated the correlation between hbv variants, their genotypes, and patients’ hbe antigen (hbeag: soluble shape of the capsid antigen) status patients and metho...

2005
Sun-Young Lee Moon Seok Choi Dongho Lee Joon Hyoek Lee Kwang Cheol Koh Seung Woon Paik Byung Chul Yoo

Disappearance of hepatitis B surface antigens (HBsAg) in chronic hepatitis B usually indicates clearance of hepatitis B virus (HBV) infection. However, false HBsAg negativity with mutations in pre-S2 and 'a' determinant has been reported. It is also known that YMDD mutations decrease the production of HBV and escape detection of serum HBsAg. Here, we report overlapping gene mutations in a patie...

2010
Chong - Gee Teo Stephen A Locarnini

Immune pressure exerted on HBV by anti-HBV antibodies and long-term therapy with drugs that mutagenize the viral P gene can select for mutations in its S gene, leading to vaccine escape and evasion from serological detection. Although transmissibility of these mutants is poor and their evolution towards heightened virulence appears slow, the situation could change as vaccination coverage increa...

2017
Ricardo Wagner de Almeida Francisco Campello do Amaral Mello Isabelle Vasconcelos Menegoy Márcia Paschoal do Espírito Santo Cléber Ferreira Ginuíno Paulo Sérgio Fonseca de Sousa Livia Melo Villar Elisabeth Lampe Lia Laura Lewis-Ximenez

BACKGROUND Many studies have identified mutations in the hepatitis B surface antigen (HBsAg) as important factors limiting the ability of commercial serological assays to detect this viral antigen. However, an association between mutations in the HBsAg gene and the occurrence of occult HBV infection (OBI) in patients has not been established. OBJECTIVES To detect hepatitis B virus (HBV) DNA i...

Journal: :hepatitis monthly 0
eleanor a. powell division of digestive disease, department of internal medicine, university of cincinnati college of medicine, cincinnati, oh, usa sanam razeghi division of digestive disease, department of internal medicine, university of cincinnati college of medicine, cincinnati, oh, usa stephen zucker division of digestive disease, department of internal medicine, university of cincinnati college of medicine, cincinnati, oh, usa jason t. blackard division of digestive disease, department of internal medicine, university of cincinnati college of medicine, cincinnati, oh, usa; division of digestive disease, department of internal medicine, university of cincinnati college of medicine, cincinnati, ml 0595, 231 albert sabin way cincinnati, oh 45267, usa. tel: +1-513-558-4389, fax: +1-513-558-1744

conclusions hbv vaccination in infancy is effective at preventing chronic hbv infection but is less effective at preventing occult hbv infection. similar studies examining the efficacy of adult hbv vaccination in preventing occult hbv have not been performed. this case highlights the importance of carefully determining the hbv status of high-risk individuals, as vaccination history and the pres...

2016
Lemonica Koumbi Teresa Pollicino Giovanni Raimondo Naveenta Kumar Peter Karayiannis Salim I. Khakoo

BACKGROUND Hepatitis B virus (HBV) is accounting for over one million deaths annually due to immune-mediated chronic liver damage. Natural killer (NK) cells are abundant in the liver and contribute in HBV persistence. NK cytotoxic effects are controlled by signals from activating and inhibitory receptors. HBV may circumvent host antiviral immunity via the regulation of NK receptors and their li...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998
S L Ngui N J Andrews G S Underhill J Heptonstall C G Teo

A retrospective case-control study was conducted to determine why some infants born full-term without obstetric intervention to hepatitis B e antigen (HBeAg)-seropositive mothers become infected by hepatitis B virus (HBV) despite having received passive-active immunoprophylaxis. Cases and controls comprised 12 hepatitis B surface antigen (HBsAg)-seropositive infants and 22 HBsAg-seronegative in...

Journal: :BMC Infectious Diseases 2004
Eneida A Santos Michel VF Sucupira Juçara Arabe Selma A Gomes

BACKGROUND Lamivudine inhibits replication of both human immunodeficiency virus (HIV) and hepatitis B virus (HBV) and is commonly used as part of antiretroviral therapy. The main limitation in the use of lamivudine is resistant mutation selection. Most of these mutations affect the YMDD motif of the HBV DNA polymerase. The resistance occurs through M550V or M550I aminoacid replacements. The M55...

Journal: :Journal of infection in developing countries 2016
Yiying Wang Lugang Yu Hui Zhou Zhiwei Zhou Huijuan Zhu Yinghui Li Zhi Zheng Xinxin Li Chen Dong

INTRODUCTION Previous studies have indicated that the patients with psychiatric illness were at higher risk of hepatitis B virus (HBV) infection. However, the efficacy of hepatitis B vaccine in schizophrenia patients remains unclear. METHODOLOGY Between June 2014 and January 2015, 415 schizophrenia patients and 3,038 controls who had been routinely immunized as infants were recruited in the p...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید